Micafungin Sodium

米卡芬净钠

Report date: 2026/05/24 20:00:34
NME

Base Information

Drug NameMicafungin Sodium
Drug Alias Name米卡芬净MicafunginumMicafungineMicaminMicafungina +[10] 
ClassificationSmall molecules > Heterocyclic drugs > AntifungalsSmall molecules > Synthetic peptide
Mechanisms of Action1,3-beta-glucan synthase inhibitorsCell wall inhibitors
Targets1,3-beta-glucan synthase
Therapy Area/IndicationsFeverGraft vs Host DiseaseFebrile Neutropenia +[23] 
Global Approved IndicationsAbscessPeritonitisCandidemia +[5] 
Approved Indications in ChinaMycoses
Original Approved Country/TerritoryJapan
Original Approved Date2002/10/08
Country/TerritoryCzechiaBelgiumBulgaria +[40] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesSandoz International GmbhSandozAstellas Pharma Europe Bv +[5] 
Inactive CompaniesRadboud University Medical CenterEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentAstellas Pharma Taiwan Inc +[6] 
Active IndicationsAbscessPeritonitisCandidemia +[5] 
Inactive IndicationsFeverGraft vs Host DiseaseFebrile Neutropenia +[18] 

Other Information

ATC CodeJ02AX05
Related LinksWikipediaDrugBankKEGG